Back to search
Lymphocyte-Rich Classical Hodgkin Lymphoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Lymphocyte-Rich Classical Hodgkin Lymphoma trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Lymphocyte-Rich Classical Hodgkin Lymphoma trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This phase II trial compares mosunetuzumab to the usual treatment (rituximab) for improving survival in patients with nodular lymphocyte-predominant Hodgkin lym…
There is a pressing need to measure patient-reported symptoms in patients of all ages diagnosed with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). Th…
This phase III trial compares immunotherapy drugs (nivolumab or brentuximab vedotin) when given with combination chemotherapy in treating patients with newly di…
This phase II trial studies how well giving brentuximab vedotin together with combination chemotherapy works in treating older patients with previously untreate…